DNA methylation, insulin resistance and second-generation antipsychotics in bipolar disorder

References

• Calkin C , Van De VeldeC , RuzickovaMet al. Can body mass index help predict outcome in patients with bipolar disorder? Bipolar. Disord. 11 ( 6 ), 650 – 656 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Goldstein BI , LiuSM , SchafferA , SalaR , BlancoC . Obesity and the three-year longitudinal course of bipolar disorder . Bipolar. Disord.15 ( 3 ), 284 – 293 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Kemp DE , GaoK , ChanPK , GanocySJ , FindlingRL , CalabreseJR . Medical comorbidity in bipolar disorder: relationship between illnesses of the endocrine/metabolic system and treatment outcome . Bipolar. Disord.12 ( 4 ), 404 – 413 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Douzenis A , SeretisD , NikaSet al. Factors affecting hospital stay in psychiatric patients: the role of active comorbidity . BMC Health Serv. Res.12 , 166 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Weiner M , WarrenL , FiedorowiczJG . Cardiovascular morbidity and mortality in bipolar disorder . Ann. Clin. Psychiatry23 ( 1 ), 40 – 47 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Laursen TM , WahlbeckK , HallgrenJet al. Life expectancy and death by diseases of the circulatory system in patients with bipolar disorder or schizophrenia in the Nordic countries . PLoS ONE8 ( 6 ), e67133 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Guo JJ , KeckPEJr , Corey-LislePKet al. Risk of diabetes mellitus associated with atypical antipsychotic use among Medicaid patients with bipolar disorder: a nested case-control study . Pharmacotherapy27 ( 1 ), 27 – 35 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Vancampfort D , VansteelandtK , CorrellCUet al. Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators . Am. J. Psychiatry170 ( 3 ), 265 – 274 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Rummel-Kluge C , KomossaK , SchwarzSet al. Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis . Schizophr. Res.123 ( 2–3 ), 225 – 233 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Nasrallah HA . Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles . Mol. Psychiatry13 ( 1 ), 27 – 35 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Reynolds GP , KirkSL . Metabolic side effects of antipsychotic drug treatment – pharmacological mechanisms . Pharmacol. Ther.125 ( 1 ), 169 – 179 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Burghardt KJ , GardnerKN , JohnsonJW , EllingrodVL . Fatty Acid desaturase gene polymorphisms and metabolic measures in schizophrenia and bipolar patients taking antipsychotics . Cardiovasc. Psychiatry Neurol.2013 , 596945 ( 2013 ).
   PubMedGoogle Scholar
• Coccurello R , MolesA . Potential mechanisms of atypical antipsychotic-induced metabolic derangement: clues for understanding obesity and novel drug design . Pharmacol. Ther.127 ( 3 ), 210 – 251 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Lann D , LeroithD . Insulin resistance as the underlying cause for the metabolic syndrome . Med. Clin. North Am.91 ( 6 ), 1063 – 1077 , viii ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Ellingrod VL , MillerDD , TaylorSF , MolineJ , HolmanT , KerrJ . Metabolic syndrome and insulin resistance in schizophrenia patients receiving antipsychotics genotyped for the methylenetetrahydrofolate reductase (MTHFR) 677C/T and 1298A/C variants . Schizophr. Res.98 ( 1–3 ), 47 – 54 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Srisawat U , ReynoldsGP , ZhangZJet al. Methylenetetrahydrofolate reductase (MTHFR) 677C/T polymorphism is associated with antipsychotic-induced weight gain in first-episode schizophrenia . Int. J. Neuropsychopharmacol.17 ( 3 ), 485 – 490 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Ellingrod VL , TaylorSF , DalackGet al. Risk factors associated with metabolic syndrome in bipolar and schizophrenia subjects treated with antipsychotics: the role of folate pharmacogenetics . J. Clin. Psychopharmacol.32 ( 2 ), 261 – 265 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Van Winkel R , MoonsT , PeerboomsOet al. MTHFR genotype and differential evolution of metabolic parameters after initiation of a second generation antipsychotic: an observational study . Int. Clin. Psychopharmacol.25 ( 5 ), 270 – 276 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Burghardt KJ , EllingrodVL . Detection of metabolic syndrome in schizophrenia and implications for antipsychotic therapy : is there a role for folate?Mol. Diagn. Ther.17 ( 1 ), 21 – 30 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Alter MD , HenR . Is there a genomic tone? Implications for understanding development, adaptation and treatment . Dev. Neurosci.31 ( 4 ), 351 – 357 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Bird A . DNA methylation patterns and epigenetic memory . Genes Dev.16 ( 1 ), 6 – 21 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• De Mello VD , PulkkinenL , LalliM , KolehmainenM , PihlajamakiJ , UusitupaM . DNA methylation in obesity and Type 2 diabetes . Ann. Med.46 ( 3 ), 103 – 113 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• First Mb , SpitzerRL , GibbonM , WilliamsJBW . Structured Clinical Interview for DSMIV Axis I Disoders ( Research version, Non-Patient Edition ). New York State Psychiatric Institute, Biometrics Research , NY, USA . ( 2002 ).
   Google Scholar
• Matthews DR , HoskerJP , RudenskiAS , NaylorBA , TreacherDF , TurnerRC . Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man . Diabetologia28 ( 7 ), 412 – 419 ( 1985 ).
   PubMed Web of Science ®Google Scholar
• Muniyappa R , LeeS , ChenH , QuonMJ . Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage . Am. J. Physiol. Endocrinol. Metab.294 ( 1 ), E15 – E26 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Borai A , LivingstoneC , KaddamI , FernsG . Selection of the appropriate method for the assessment of insulin resistance . BMC Med. Res. Methodol.11 , 158 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Karimi M , JohanssonS , EkstromTJ . Using LUMA: a LUminometric-based assay for global DNA-methylation . Epigenetics1 ( 1 ), 45 – 48 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Karimi M , JohanssonS , StachDet al. LUMA (LUminometric Methylation Assay) – a high throughput method to the analysis of genomic DNA methylation . Exp. Cell. Res.312 ( 11 ), 1989 – 1995 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Pilsner JR , LazarusAL , NamDHet al. Mercury-associated DNA hypomethylation in polar bear brains via the LUminometric Methylation Assay: a sensitive method to study epigenetics in wildlife . Mol. Ecol.19 ( 2 ), 307 – 314 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Virani S , DolinoyDC , HalubaiSet al. Delivery type not associated with global methylation at birth . Clin. Epigenetics4 ( 1 ), 8 ( 2012 ).
   PubMedGoogle Scholar
• Lumey LH , TerryMB , Delgado-CruzataLet al. Adult global DNA methylation in relation to pre-natal nutrition . Int. J. Epidemiol.41 ( 1 ), 116 – 123 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Tajuddin SM , AmaralAF , FernandezAFet al. Genetic and non-genetic predictors of LINE-1 methylation in leukocyte DNA . Environ. Health Perspect.121 ( 6 ), 650 – 656 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Bae S , UlrichCM , BaileyLBet al. Impact of folic acid fortification on global DNA methylation and one-carbon biomarkers in the Women’s Health Initiative Observational Study cohort . Epigenetics9 ( 3 ), 396 – 403 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Piyathilake CJ , BadigaS , AlvarezRD , PartridgeEE , JohanningGL . A lower degree of PBMC L1 methylation is associated with excess body weight and higher HOMA-IR in the presence of lower concentrations of plasma folate . PLoS ONE8 ( 1 ), e54544 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Simar D , VersteyheS , DonkinIet al. DNA methylation is altered in B and NK lymphocytes in obese and type 2 diabetic human . Metabolism63 ( 9 ), 1188 – 1197 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Zhao J , GoldbergJ , BremnerJD , VaccarinoV . Global DNA methylation is associated with insulin resistance: a monozygotic twin study . Diabetes61 ( 2 ), 542 – 546 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Pearce MS , McconnellJC , PotterCet al. Global LINE-1 DNA methylation is associated with blood glycaemic and lipid profiles . Int. J. Epidemiol.41 ( 1 ), 210 – 217 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Lott SA , BurghardtPR , BurghardtKJ , BlyMJ , GroveTB , EllingrodVL . The influence of metabolic syndrome, physical activity and genotype on catechol-O-methyl transferase promoter-region methylation in schizophrenia . Pharmacogenomics J.13 ( 3 ), 264 – 271 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Burghardt KJ , PilsnerJR , BlyMJ , EllingrodVL . DNA methylation in schizophrenia subjects: gender and MTHFR 677C/T genotype differences . Epigenomics4 ( 3 ), 261 – 268 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Moons T , De HertM , KenisGet al. No association between genetic or epigenetic variation in insulin growth factors and antipsychotic-induced metabolic disturbances in a cross-sectional sample . Pharmacogenomics15 ( 7 ), 951 – 962 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Melas PA , RogdakiM , OsbyU , SchallingM , LavebrattC , EkstromTJ . Epigenetic aberrations in leukocytes of patients with schizophrenia: association of global DNA methylation with antipsychotic drug treatment and disease onset . FASEB J.26 ( 6 ), 2712 – 2718 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Melka MG , LauferBI , McdonaldPet al. The effects of olanzapine on genome-wide DNA methylation in the hippocampus and cerebellum . Clin. Epigenetics6 ( 1 ), doi:10.1186/1868-7083-6-1 ( 2014 ).
   PubMedGoogle Scholar
• Haffner SM , MykkanenL , FestaA , BurkeJP , SternMP . Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state . Circulation101 ( 9 ), 975 – 980 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Chen J , WildmanRP , HammLLet al. Association between inflammation and insulin resistance in U.S. nondiabetic adults: results from the Third National Health and Nutrition Examination Survey . Diabetes Care27 ( 12 ), 2960 – 2965 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Mitchell AJ , DelaffonV , VancampfortD , CorrellCU , De HertM . Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices . Psychol. Med.42 ( 1 ), 125 – 147 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Guha P , BhowmickK , MazumderP , GhosalM , ChakrabortyI , BurmanP . Assessment of insulin resistance and metabolic syndrome in drug naive patients of bipolar disorder . Indian J. Clin. Biochem.29 ( 1 ), 51 – 56 ( 2014 ).
   PubMedGoogle Scholar
• Coppola G , KarydasA , RademakersRet al. Gene expression study on peripheral blood identifies progranulin mutations . Ann. Neurol.64 ( 1 ), 92 – 96 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Coppola G , BurnettR , PerlmanSet al. A gene expression phenotype in lymphocytes from Friedreich ataxia patients . Ann. Neurol.70 ( 5 ), 790 – 804 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Jaffe AE , IrizarryRA . Accounting for cellular heterogeneity is critical in epigenome-wide association studies . Genome Biol.15 ( 2 ), R31 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Talens RP , BoomsmaDI , TobiEWet al. Variation, patterns, and temporal stability of DNA methylation: considerations for epigenetic epidemiology . FASEB J.24 ( 9 ), 3135 – 3144 ( 2010 ).
   PubMed Web of Science ®Google Scholar